Anne Jacquet-Bescond

Title: Anne Jacquet-Bescond: Innovator in Cancer Treatment

Introduction

Anne Jacquet-Bescond is a notable inventor based in Le Plessis Robinson, France. She has made significant contributions to the field of cancer treatment through her innovative research and development. Her work focuses on the administration of specific compounds that enhance therapeutic outcomes for patients.

Latest Patents

Anne Jacquet-Bescond holds a patent for an administration regime involving N-hydroxy-4-{2-[3-(N,N-dimethylaminomethyl)benzofuran-2-ylcarbonylamino]ethoxy}benzamide. This compound is utilized in conjunction with surgery, chemotherapy, or radiotherapy for cancer treatment. The unique aspect of her patent is the specific administration schedule, which consists of four consecutive days of treatment followed by three days without administration, ensuring optimal efficacy while avoiding certain chemotherapy regimens like FOLFOX.

Career Highlights

Throughout her career, Anne has worked with prominent companies in the pharmaceutical industry, including Les Laboratoires Servier and Pharmacyclics, Inc. Her experience in these organizations has allowed her to develop and refine her innovative approaches to cancer treatment.

Collaborations

Anne has collaborated with esteemed colleagues such as Marylore Chenel and Sriram Balasubramanian. These partnerships have contributed to her success and the advancement of her research in the field.

Conclusion

Anne Jacquet-Bescond is a pioneering inventor whose work in cancer treatment exemplifies the impact of innovation in medicine. Her contributions continue to influence the development of effective therapeutic strategies for patients.